TTP LabTech to showcase new high sensitivity laser scanning microplate cytometer TTP LabTech will be showcasing its new Mirrorball™ high sensitivity laser scanning microplate cytometer for antibody discovery at the ELRIG Drug Discovery 2010 event, Coventry, UK, 1-2 September. As part of the European launch of Mirrorball, TTP LabTech will be presenting a snapshot abstract of supporting performance data in the Assay Development and Screening session titled ‘Mix-and-Read Screening for Antibody Discovery’, on 1 September at 12.15-12.45pm.

Mirrorball is the first microplate cytometer to offer simultaneous laser scanning, enabling superior multiplexing and resulting in higher throughput single pass scanning. Filling a critical role by rapidly and reliably performing mix-and–read, cell- or bead-based assays, the TTP LabTech Mirrorball can significantly advance the antibody discovery process. The poster ‘A Mix-and-Read Cell-Based Assay for Antibody Screening Against Epithelial Growth Factor Receptor’ will be presented by TTP LabTech during the conference, demonstrating Mirroball’s superior functionality.

Joining the new Mirrorball on stand E2 will be TTP LabTech’s world renowned mosquito® liquid handler and the Acumen® eX3 high content screening platform. Posters demonstrating the high level performance of each of these instruments will also be presented during ELRIG Drug Discovery 2010.

Visit stand E2 for more information on Mirrorball, mosquito and the Acumen eX3 or visit www.ttplabtech.com. To book a product demo please mail sales@ttplabtech.com.

Editors’ notes
About TTP LabTech Ltd
Based near Cambridge, UK, TTP LabTech supplies laboratory instrumentation and provides contract screening services for the healthcare, biotech and pharmaceutical sectors. TTP LabTech’s products are designed to increase efficiency, effectiveness, flexibility or overall capability in key biopharmaceutical research processes including compound storage (comPOUND®), low volume liquid handling (mosquito®), fluorescence detection (Acumen®) and antibody discovery (Mirrorball™). With offices in the UK, North America, and China the company is able to manage and support its innovative products in virtually all parts of the world.